[
  {
    "ts": "2025-10-15T13:03:00+00:00",
    "headline": "Deck Bio and ReTrax Therapeutics Awarded 2025 Bristol Myers Squibb Golden Tickets",
    "summary": "LabCentral today announced that Deck Bio and ReTrax Therapeutics were awarded LabCentral Golden Tickets sponsored by Bristol Myers Squibb (BMS). The prizes were awarded on October 8, 2025, during the final round of evaluations, which are judged by leaders from BMS.",
    "url": "https://finance.yahoo.com/news/deck-bio-retrax-therapeutics-awarded-130300226.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "dfb2fb37-4555-3b18-b5ad-5752cb99063d",
      "content": {
        "id": "dfb2fb37-4555-3b18-b5ad-5752cb99063d",
        "contentType": "STORY",
        "title": "Deck Bio and ReTrax Therapeutics Awarded 2025 Bristol Myers Squibb Golden Tickets",
        "description": "",
        "summary": "LabCentral today announced that Deck Bio and ReTrax Therapeutics were awarded LabCentral Golden Tickets sponsored by Bristol Myers Squibb (BMS). The prizes were awarded on October 8, 2025, during the final round of evaluations, which are judged by leaders from BMS.",
        "pubDate": "2025-10-15T13:03:00Z",
        "displayTime": "2025-10-15T13:03:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/9d0e169caf26be5a9a32dddaea1ddb03",
          "originalWidth": 400,
          "originalHeight": 124,
          "caption": "LabCentral logo. (PRNewsFoto/LabCentral) (PRNewsfoto/LabCentral)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AOm0s6KI4idnhcBP58z8ew--~B/aD0xMjQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/9d0e169caf26be5a9a32dddaea1ddb03.cf.webp",
              "width": 400,
              "height": 124,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SgouBukLrVV4qrAaoKSPBw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/9d0e169caf26be5a9a32dddaea1ddb03.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/deck-bio-retrax-therapeutics-awarded-130300226.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/deck-bio-retrax-therapeutics-awarded-130300226.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-15T11:00:00+00:00",
    "headline": "Bristol Myers Squibb Foundation Announces $1 Million Donation to Patient Advocate Foundation",
    "summary": "New contribution will help expand access to care by strengthening the Patient Advocate Foundation's capacity to deliver essential services and case management to vulnerable patients NORTHAMPTON, MA / ACCESS Newswire / October 15, 2025 / The Bristol ...",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-foundation-announces-110000843.html",
    "source": "ACCESS Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "6dfb7c5a-1e0a-304f-b328-75e4076755cc",
      "content": {
        "id": "6dfb7c5a-1e0a-304f-b328-75e4076755cc",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb Foundation Announces $1 Million Donation to Patient Advocate Foundation",
        "description": "",
        "summary": "New contribution will help expand access to care by strengthening the Patient Advocate Foundation's capacity to deliver essential services and case management to vulnerable patients NORTHAMPTON, MA / ACCESS Newswire / October 15, 2025 / The Bristol ...",
        "pubDate": "2025-10-15T11:00:00Z",
        "displayTime": "2025-10-15T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "ACCESS Newswire",
          "url": "https://www.accessnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-foundation-announces-110000843.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-foundation-announces-110000843.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CELG-RT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-15T06:19:48+00:00",
    "headline": "Bristol-Myers Squibb (BMY) Expands Cell Therapy Portfolio with $1.5 Billion Orbital Therapeutics Deal",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 11 Low PE High Dividend Stocks to Buy According to Analysts. Bristol-Myers Squibb Company (NYSE:BMY) is a global pharmaceutical company. It announc‌ed on​ October 10 that it will acquir‌e privately held cell ther‌ap‌y de​veloper Orbital Therapeut‌ics⁠ for $1.5 billion⁠ in cash, in an ef‍for⁠t to‌ diver‌sify‌ away‌ […]",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-expands-061948595.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "89ea2c8b-0bfa-3db0-968f-1405645bbf0c",
      "content": {
        "id": "89ea2c8b-0bfa-3db0-968f-1405645bbf0c",
        "contentType": "STORY",
        "title": "Bristol-Myers Squibb (BMY) Expands Cell Therapy Portfolio with $1.5 Billion Orbital Therapeutics Deal",
        "description": "",
        "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 11 Low PE High Dividend Stocks to Buy According to Analysts. Bristol-Myers Squibb Company (NYSE:BMY) is a global pharmaceutical company. It announc‌ed on​ October 10 that it will acquir‌e privately held cell ther‌ap‌y de​veloper Orbital Therapeut‌ics⁠ for $1.5 billion⁠ in cash, in an ef‍for⁠t to‌ diver‌sify‌ away‌ […]",
        "pubDate": "2025-10-15T06:19:48Z",
        "displayTime": "2025-10-15T06:19:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Bristol-Myers Squibb (BMY) Expands Cell Therapy Portfolio with $1.5 Billion Orbital Therapeutics Deal",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w_.mq2hxLlg_y2nUTx72ng--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t6o8Kx8kFVS_oEolQVNGNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-expands-061948595.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-expands-061948595.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]